Clinical trial

Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma

NCT06761313

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-03-01

PhasePHASE4

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2025-01-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaverified · MONDO: glaucoma

Quality of Life (QOL)unresolved

Interventions

Triple combination formulaDRUG

Bimatoprost .03% sterile ophthalmic solutionDRUG

Sponsors & collaborators

Federal University of São Paulolead sponsor

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06761313 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.